McN-4612
| Clinical data | |
|---|---|
| Other names | Mcn 4612 |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C18H19N |
| Molar mass | 249.357 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
McN-4612 is a noradrenaline-preferring serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) developed by McNeil Laboratories in the 1980s.